mycophenolate mofetil (Myfenax)
116B8
Approved small_molecule terminated
Quick answer
mycophenolate mofetil (Myfenax) for Stable Renal Transplant Recipients is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Stable Renal Transplant Recipients
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated